The effect of exemestane or tamoxifen on markers of bone turnover: results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial. Hadji, P., Ziller, M., Kieback, D.G., Menschik, T., Kalder, M., Kuck, J., Hasenburg, A., 2009. Breast 18, 159–164. doi:10.1016/j.breast.2009.03.003 Abstract Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy. Hadji, P., Ziller, M., Kieback, D.G., Dornoff, W., Tessen, H.W., Menschik, T., Kuck, J., Melchert, F., Hasenburg, A., 2009. Ann Oncol 20, 1203–1209. doi:10.1093/annonc/mdn762… Weiterlesen Bendamustine in the treatment of chronic lymphocytic leukemia. Knauf, W., 2009 Expert Rev Anticancer Ther 9, 165–174. doi:10.1586/14737140.9.2.165 Abstract… Weiterlesen